Table 4.
Endpoints of hospitalized patients during Delta and Omicron waves with regard to remdesivir (RDV) treatment.
| Delta | Omicron | |||||
|---|---|---|---|---|---|---|
| RDV (n = 490) |
NO AVT (n = 680) |
p | RDV (n = 272) |
NO AVT (n = 380) |
p | |
| Need for oxygen therapy, % (n) | 75.9 (372) | 77.1 (524) | >0.05 | 59.6 (162) | 50.3 (191) | 0.01 |
| Need for mechanical ventilation, % (n) | 7.8 (38) | 9.4 (63) | >0.05 | 2.2 (6) | 4.0 (15) | >0.05 |
| Mortality, % (n) | 10.8 (53) | 23.2 (158) | <0.001 | 11.4 (31) | 16.8 (64) | 0.05 |
| Age of patients who died (years), mean ± SD (min–max) | 75.6 ± 13.9 (34–95) |
76.5 ± 12.9 (30–99) |
>0.05 | 77.7 ± 12.4 (37–95) |
79.0 ± 14.2 (25–99) |
>0.05 |
Abbreviations: AVT, antiviral therapy; RDV, remdesivir; SD, standard deviation.